Journal of Medical Economics
Volume 22, 2019 - Issue 10
Open access
4,117
Views
16
CrossRef citations to date
0
Altmetric
Diabetes
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden
Åsa EricssonNovo Nordisk Scandinavia AB, Malmo, Sweden; Correspondence[email protected]
& Adam FridhammarThe Swedish Institute for Health Economics, Lund, Sweden
Pages 997-1005
|
Received 05 Feb 2019, Accepted 28 Apr 2019, Published online: 23 May 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.